Clinical Study

Effects of Home-Based Robotic Therapy Involving the Single-Joint Hybrid Assistive Limb Robotic Suit in the Chronic Phase of Stroke: A Pilot Study

Table 2

Paretic upper limb activity and upper limb function.

CaseMALAccelerometerFMA-UEARAT

AOULaterality indexTotalProximalDistalTotal
(0–5)(-1 to +1)(0–66)(0–42)(0–24)(0–57)

Baseline
12.8-0.16
66422457
21.0-0.6050371337
30.5-0.2255342134
41.1-0.3845351023
51.6-0.4261372453
62.2-0.4052371526
73.1-0.0761372456
80-0.7343202322
90-0.37151503
100.3-0.3251331826
Mean±SD1.3±1.1-0.37±0.249.9±13.532.8±8.017.2±7.533.7±16.5

Post
13.7-0.1766422457
21.3-0.4251381339
31.0-0.2257362142
41.5-0.3445351023
53.0-0.2362382454
62.5-0.4053381527
73.4-0.0261372457
80.7-0.5443202326
92.6-0.35151503
101.1-0.2751331829
Mean±SD±1.0±0.150.4±13.733.2±8.217.2±7.5±16.5

Follow-up
14.3-0.1866422457
21.3-0.3151381341
30.9-0.3356352142
41.7-0.3445351023
53.9-0.1762382453
62.5-0.3252371528
73.9-0.0661372457
80.6-0.7043202327
91.2-0.37151503
101.4-0.3248301833
Mean±SD±1.3-0.31±0.249.9±13.732.7±8.317.2±7.5±16.3

MAL: Motor Activity Log, AOU: amount of use, accelerometer: arm triaxial accelerometer, FMA-UE: Fugl–Meyer assessment-upper extremity, and ARAT: action research arm test; (Wilcoxon signed-rank test).